Objective(s): Herpes simplex virus (HSV) infections in immunocompromised individuals may require prolonged antiviral therapy resulting in the emergence of viral strains resistant to the currently employed antiviral drugs. Distamycin A (DA), a basic antibiotic belonging to the lexitropsin DNA minor groove binding drugs, exhibits antiviral properties. In this study we evaluated the in vitro cytotoxicity and antiviral activity of DA against HSV type 1 and HSV type 2 clinical isolates from transplanted patients and compared them with those of acyclovir (ACV) in search of alternative antiviral drugs. Methods: Viral detection and typing was performed by multiplex PCR and immunofluorescence assay; the in vitro cytotoxicity of DA and the antiviral activity of ACV and DA was evaluated respectively by neutral red uptake assay andplaque reduction assay for HSV2 isolates and fluorescence reduction assay for HSV1 isolates. Results: Tissue culture 50% cytotoxic concentration of DA was 58 M . Tissue culture 50% inhibitory concentration values ranged from 0.16 to 7.4 M for the ACV-sensitive and from 5.4 to 32 M for the ACVresistant viral strains. Conclusions: In spite of the lower activity against ACV-resistant strains, DA may be used as an antiherpetic drug.
|Autori:||MATTEOLI B; BERNARDINI S; IULIANO R; PARENTI S; FREER GIULIA; BROCCOLO F; BAGGIANI A; SUBISSI A; ARCAMONE F; CECCHERINI NELLI LUCA|
|Titolo:||In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients|
|Anno del prodotto:||2008|
|Digital Object Identifier (DOI):||10.1159/000148199|
|Appare nelle tipologie:||1.1 Articolo in rivista|